Last reviewed: September 10, 2026 | U.S. cosmetic compliance for international beauty brands
For a brand launching cosmetics in the United States, MoCRA changes the diligence expected from the business behind the label and from its manufacturing partners. The practical task is to assign the right legal role, keep the marketed formula and label tied to evidence, and use FDA’s current guidance rather than treating a registration number as a product passport.
What is MoCRA?
The Modernization of Cosmetics Regulation Act of 2022 amended the Federal Food, Drug, and Cosmetic Act. FDA administers the federal cosmetic framework. Its current guidance explains that, subject to statutory exemptions and qualifications, manufacturers and processors register facilities and the responsible person lists marketed cosmetic products and supplies updates. FDA also states that registration or listing is not an FDA approval and that it does not issue certificates proving registration or listing.
What MoCRA does—and does not—mean
| Requirement area | Practical purpose | It does not mean |
|---|---|---|
| Facility registration | Records certain manufacturing or processing facilities with FDA. | That FDA approved every cosmetic made there. |
| Product listing | Gives FDA information about marketed cosmetic products and ingredients through the responsible person. | That the product, claims or label were pre-cleared. |
| Safety substantiation | Requires the responsible person to maintain adequate support for safety. | That one generic test report covers every formula, pack and intended use. |
| Serious adverse-event process | Creates an FDA reporting and recordkeeping pathway for serious adverse events. | That ordinary customer feedback can be ignored. |
Who is the “responsible person”?
FDA describes the responsible person as the manufacturer, packer or distributor of a cosmetic whose name appears on the product label in accordance with the statute. For a private-label or contract-manufactured product, that may not be the same business as the factory. Contracts should not guess: map the entity printed on the U.S. label, the entity controlling final claims, and the entity expected to maintain the product listing and safety documentation.
| Role | Typical contribution | Brand-side question to settle |
|---|---|---|
| Responsible person | Lists marketed cosmetics, maintains safety substantiation and handles relevant adverse-event duties. | Whose name and U.S. contact details appear on the final label? |
| Facility operator | Assesses whether the facility must register and maintain its registration. | Which sites actually manufacture or process the marketed product? |
| Brand owner | Controls commercial claims, approved artwork, product positioning and launch decisions. | Does the final label and claim set match the evidence and legal classification? |
| OEM/ODM manufacturer | Can provide formula, INCI, quality, batch and technical support records. | Which documents are available, current and contractually transferable? |
Facility registration and product listing are separate
A common mistake is to ask a manufacturer for “FDA approval” or a universal “FDA certificate.” FDA distinguishes facility registration from product listing. The facility operator handles the registration question, while the responsible person submits the listing for each marketed cosmetic product, including ingredient information. FDA’s guidance also notes that some small businesses may qualify for exemptions, with important exceptions. Confirm the exact product category and business facts with current FDA guidance before relying on an exemption.
What evidence should a brand keep?
MoCRA is not a one-document exercise. A sensible U.S. launch file links the final commercial product to traceable support. The appropriate evidence depends on the formula, ingredients, intended use, exposure, package and claims.
| File item | Why it matters | Likely contributor |
|---|---|---|
| Controlled formula and INCI list | Connects the product listing, ingredient review and final pack. | Manufacturer and brand approval team. |
| Final artwork and claims file | Helps distinguish cosmetic positioning from claims that may change regulatory classification. | Brand owner, regulatory reviewer and label designer. |
| Safety substantiation rationale | Supports the responsible person’s safety determination for the marketed product. | Responsible person with qualified technical support. |
| Batch, quality and complaint records | Supports traceability, investigations and post-market response. | Manufacturer, distributor and responsible person. |
| Adverse-event procedure | Defines intake, escalation, records and any FDA reporting decision. | Responsible person and customer-care owner. |
Claims can change the analysis
FDA’s cosmetics information repeatedly distinguishes cosmetics from drugs. A product’s intended use can be established by claims, consumer perception and other factors. “Moisturizes the appearance of dry skin” and a claim to treat, prevent or affect a disease or body structure are not interchangeable statements. Review final website, marketplace and social copy alongside the carton and label; a formula being sold as a cosmetic does not make every claim cosmetic.
A MoCRA launch checklist for international brands
- Identify the entity that will be the U.S. responsible person for the final label.
- Map every manufacturing and processing site and ask whether the facility registration rules apply.
- Freeze the U.S. formula, INCI declaration, packaging and claims before listing.
- Build and retain safety substantiation appropriate to the marketed product.
- Confirm the responsible person’s product-listing plan, including annual update responsibilities.
- Set a documented serious adverse-event intake and escalation process.
- Use change control: review new claims, new shades, formula changes and relabels before sale.
What a cosmetic manufacturer can provide
MOOYAM can support an international brand with manufacturing and technical documentation such as an INCI list, certificate of analysis, SDS where applicable, manufacturing documentation, stability information, microbiological reports, quality records, packaging compatibility information and batch documentation. Those records support a brand’s compliance workflow; they do not replace the responsible person’s legal assessment or transform a cosmetic into an FDA-approved product.
Official FDA references
| FDA resource | Use it for |
|---|---|
| MoCRA overview | Statutory modernization and FDA implementation information. |
| Registration and listing of facilities and products | Current filing roles, renewals, updates, exemptions and the no-approval distinction. |
| FDA cosmetics FAQs | Core U.S. cosmetic safety, labeling and regulatory context. |
FAQ
Does MoCRA mean FDA approves cosmetics before sale?
No. FDA registration and listing do not mean FDA has approved a cosmetic product. FDA says it does not issue certificates to verify registration or listing.
Does every cosmetic factory need FDA registration?
FDA’s requirements include exemptions and exceptions. Confirm the actual activity, facility and product facts under current FDA guidance rather than relying on a supplier’s informal statement.
Can an overseas manufacturer be the responsible person?
The answer depends on the entity named on the label and the statutory definition. Define the responsible person in the U.S. launch plan and contract before the product is listed.
Is a product listing the same as an FDA product license?
No. Do not describe product listing as an FDA product license or approval unless a separate legal framework expressly applies.
Regulatory requirements may change. Brands should verify current requirements with FDA or a qualified compliance professional before placing cosmetic products on the U.S. market.